Sumitomo Dainippon Pharma Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sumitomo Dainippon Pharma Co Ltd with three other
pharmaceutical manufacturers in Asia:
Kissei Pharmaceutical Company Limited
sales of 71.71 billion Japanese Yen [US$640.33 million]
of which 86%
was Pharmaceutical Products),
Hisamitsu Pharmaceutical Co Inc
(145.93 billion Japanese Yen [US$1.30 billion]
of which 100%
was Pharmaceuticals), and
Sun Pharmaceuticals Industries Ltd
based in India
(315.78 billion Indian Rupees [US$4.91 billion]
Sumitomo Dainippon Pharma Co Ltd reported sales of ¥411.64 billion (US$3.68 billion)
March of 2017.
increase of 2.1%
versus 2016, when the company's sales were ¥403.21 billion.